This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Biosimulation Market

Surge in penetration of software in healthcare to augment the demand of biosimulation: Opportunities ahead

Biosimulation Market by Product Type, Deployment Mode, End Use & Region - Forecast 2022 - 2032

Biosimulation Market Outlook (2022-2032)

The Global Biosimulation Market was valued at around US$ 2.6 Bn in 2021, with a projected CAGR 21.5% for the next ten years; the market is likely to reach a valuation of US$ 20.9 Bn by the end of 2032. The need for developing new drugs to compact the developing diseases will drive the demand for biosimulation.

Report Attributes

Details

Estimated Market Value (2022E)

US$ 3.1 Bn

Forecasted Market Value (2032F)

US$ 20.9 Bn

Global Market Growth Rate (2022-2032)

21.5% CAGR

United States Growth Rate (2022-2032)

~21.6% CAGR

Key Companies Covered

  • Certara
  • Dassault Systemes
  • Advanced Chemistry Development
  • Simulation Plus Inc
  • Schrodinger, Inc.
  • Chemical Computing Group
  • Physiomics Plc
  • Rosa & Co. LLC
  • BioSimulation Consulting Inc.
  • Genedata AG
  • Instem Group of Companies
  • PPD, Inc.
  • Insilico Biotechnology AG
  • Rhenovia Pharma
  • LeadInvent Technologies
  • Nuventra Pharma
  • In Silico Biosciences

Future Market Insight’s analysis reveals that the most of the revenue is generated from biosimulation software. On the other hand, drug development in deployment mode will be the most lucrative with a CAGR 22.8% during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sale Analysis of Biosimulation from 2015 to 2021 Vs Market Outlook For 2022 to 2032

The global market for Biosimulation registered a CAGR of 15.8% during 2015-2021. The market growth is projected to surge due to technological advancement in software for biosimulation. In 2021, the global market size of biosimulation was valued at US$ 2.6 Bn and is estimated to increase to a valuation of US$ 3.1 Bn in 2022.

Biosimulation is the use of computer-aided mathematical models to simulate biological processes. Biosimulation has various applications like developing new drugs and discovering new drugs. The drug discovery and development process is expensive, and the failure of a therapeutic molecule in the late stages of drug development results in a massive waste of time, money, and other resources. As a result, a predictive tool is required to aid in predicting the future results of drug development through simulation of the biological processes involved.

Biosimulation helps to simulate the effect of drugs on the body with the help of simulation. Pharmaceutical manufacturers are using biosimulation throughout the drug development process to identify the positive and negative effects of their drug can have on the people if the drug is used.

The global biosimulation market has predicted to surge ahead at a CAGR of 21.5% and record sales worth US$ 20.9 Bn by the end of 2032. US will continue to be the largest procurer of biosimulation throughout the analysis period accounting for over US$ 7.5 Bn absolute dollar opportunity in the coming 10-year epoch.

How will the Reduction in Operating Costs of Pharmaceutical Companies through Biosimulation Stimulate Market Growth?

Rising global healthcare spending will increase spending on developing drugs, which will drive revenue for biosimulation. Many drugs for mimic diseases are developed using biosimulation. Computers operating sickness simulations with the aid of biosimulation software can be used to conduct virtual clinical trials for new pharmaceutical treatments. Developing a new drug requires significant research and studies. Every stage of drug development from clinical trials to the approval of the drug has a serious chance of failure. Biosimulation lowers these odds by predicting these failures in the development process. Also, it lowers the cost of pharmaceutical companies by lowering the number of clinical trials.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What factors are Restraining the Biosimulation Market?

Biosimulation uses mathematical equations to depict a real-life process that occurs within the human body. Researchers may simulate a wide range of scenarios and examine the behavior of a human system in diverse settings since it can duplicate human biological elements and their interactions with medications when they are put into the system.

In order to obtain a better result, skilled expertise is required to perform the biosimulation software. The demand for skilled expertise is high in research laboratories and companies. In addition, this process is very complex and highly technical as they involve various laboratory documentation systems. In order to overcome this issue, researchers must receive proper training and assistance. These factors make biosimulation development time-consuming, thus limiting its adoption among researchers.

Regional -Wise Insights

How is the demand for Biosimulation shaping up in North America?

North America holds the largest market for biosimulation. The rising chronic disease among the population in the region and regulations implemented by the governments for patient safety and treatment standards is driving the demand for biosimulation in the region. In silico modeling is being used to boost the standard of patient care and safety. This is particularly true for the implementation of regulatory laws that have high standards for the safety and care of patients.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Country-Wise Insights

US Biosimulation Market Analysis

The encouraging government policies in the US and the rising healthcare expenditure due to the dominance of chronic diseases are key factors that are rising drug development and discovery in the US. The market for biosimulation in the US has projected to reach a valuation of US$ 8.7 Bn in 2032.

China Biosimulation Market Analysis

The government policies for developing quality pharmaceutical drugs and the Chinese government‘s commitment to develop and increase innovation in its healthcare system is driving the market for biosimulation in China. Chinese government’s plan to be a global leader in drug development is attracting drug development and pharmaceutical companies to China for the development of new drugs, which will further increase the demand for the biosimulation market over the years. The market for biosimulation in China is forecasted to reach a valuation of US$ 1.7 Bn by 2032.

U.K. Biosimulation Market Analysis

The market in the U.K. is projected to reach a valuation of US$ 880 Mn by 2032. The market is expected to grow at a CAGR of 20.6% during 2022 – 2032 to gross an absolute dollar opportunity of US$ 336 Mn.

Japan Biosimulation Market Analysis

The market for biosimulation in Japan is expected to reach US$ 1.2 Bn by 2032. Growing at a CAGR of 25.1% during the forecast period, the market is likely to garner an absolute dollar opportunity of US$ 1.1 Bn.

Category-Wise Insights

How is Biosimulation revenue through CROs going to perform over the forecast years?

The market through the CROs segment is anticipated to grow at the fastest rate during the forecast period. The growing tendency of firms to cut total spending is expected to drive segment growth. Other factors like increased efficiency and the ability to focus on core areas for company development will also drive the use of biosimulation in CROs.

Competitive Landscape

The key companies operating in the biosimulation market include Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus Inc., Schrodinger, Inc., Chemical Computing Group, Physiomics Plc, Rosa & Co. LLC, BioSimulation Consulting Inc., Genedata AG, Instem Group of Companies, PPD, Inc., Insilico Biotechnology AG, Rhenovia Pharma, LeadInvent Technologies, Nuventra Pharma, and In Silico Biosciences.

Some of the recent developments by key providers of biosimulation are as follows:

  • In June 2022, Certara announced its new version of Biosimulation software for the progress of Novel Biologics. The new version includes Immunogenicity (IG), Immuno-Oncology (IO), and Vaccine simulators to understand and predict how drugs work and point out the key questions in the development of novel biologic therapies.
  • In June 2022, Genedata AG announced that Syros Pharmaceuticals has chosen Genedata AG’s Genedata Profiler as its data integration and investigative platform to accelerate its translational research strategy.
  • In March 2022, Advanced Chemistry labs announced that Pharmaron Inc. has chosen its NMR processing and interpretation software.
  • In March 2022, Simulation Plus, Inc. released its Membrane Plus 3.0 software. The new software includes improved data handling and simulation performance for in vitro-in vivo for extrapolation (IVIVE) for permeability, skin penetration and release assay systems.
  • In February 2022, the US Food and Drug Administration (FDA) approved the license for Certara’s Immunogenicity (IG) stimulator to research and assess immunogenicity in protein-based remedies.
  • In February 2022, Physiomics Plc updated a new agreement with ValiRx plc. According to the new agreement, ValiRx will be able to use Physiomics Plc’s latest version of its Virtual Tumour technology. Physiomics Plc will also help ValiRx in modeling the use of VAL201 peptide in endometriosis (VAL301) and Coronavirus (BC201).
  • In December 2021, Certara announced the release of Pinnacle 21 enterprise 5.1.0, which advances the software for making Clinical trial data for biosimulation and regulatory submission.
  • In September 2021, Instem Group of Companies acquired PDS Life Sciences (PDS). This acquisition will help Instem Group of Companies increase their research and development process and enable them to quickly develop and deliver solutions to their clients.
  • In March 2021, Instem Group of Companies acquired d-wise a clinical trial and technology and consulting company. Through this acquisition, Instem Group of Companies plans to bring their products faster to the market. The consolidation will also accelerate their research and development process in Insilico modeling and prediction solutions.

Similarly, the team at Future Market Insights has tracked recent developments related to companies offering Biosimulation, which is available in the full report.

Key Segments Covered in Biosimulation Industry Survey

Biosimulation Market by Product Type:

  • Services
    • In-house services
    • Contract services
  • Software

Biosimulation Market by Deployment Mode:

  • Drug Development
  • Drug Discovery
  • Other Applications

Biosimulation Market by End-use:

  • Pharmaceutical &Biotechnology Companies
  • CROs
  • Regulatory Authorities
  • Academic Research Instituitons

Biosimulation Market by Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The global biosimulation market was valued at US$ 2.6 Bn in 2021.

The biosimulation industry is set to witness a high growth rate of 21.5% over the forecasted period and be valued at US$ 20.9 Bn by 2032.

The Biosimulation Market expanded at a CAGR of 15.8% from 2015 through 2021.

Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus Inc, and Schrodinger, Inc. are the key providers of biosimulation.

US, UK, China Japan and South Korea are expected to drive the most sales growth of Biosimulation.

The market in the US has forecasted to account for over 40% of the global market share in 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Investment Feasibility Matrix

    3.4. Regulatory Landscape

        3.4.1. By Key Regions

        3.4.2. By Key Countries

4. Global Market Analysis 2015-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2015-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2015-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Software

        5.3.2. Services

            5.3.2.1. In-house Services

            5.3.2.2. Contract Services

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2015-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Deployment Mode

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Deployment Mode, 2015-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Deployment Mode, 2022-2032

        6.3.1. Drug Development

        6.3.2. Drug Discovery

        6.3.3. Other Applications

    6.4. Y-o-Y Growth Trend Analysis By Deployment Mode, 2015-2021

    6.5. Absolute $ Opportunity Analysis By Deployment Mode, 2022-2032

7. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End Use

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2015-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032

        7.3.1. Pharmaceutical & Biotechnology Companies

        7.3.2. CROs

        7.3.3. Regulatory Authorities

        7.3.4. Academic Research Institutions

    7.4. Y-o-Y Growth Trend Analysis By End Use, 2015-2021

    7.5. Absolute $ Opportunity Analysis By End Use, 2022-2032

8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2015-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Deployment Mode

        9.2.4. By End Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Deployment Mode

        9.3.4. By End Use

    9.4. Key Takeaways

10. Latin America Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Argentina

            10.2.1.4. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Deployment Mode

        10.2.4. By End Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Deployment Mode

        10.3.4. By End Use

    10.4. Key Takeaways

11. Europe Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. Russia

            11.2.1.7. BENELUX

            11.2.1.8. Rest of Europe

        11.2.2. By Product Type

        11.2.3. By Deployment Mode

        11.2.4. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Deployment Mode

        11.3.4. By End Use

    11.4. Key Takeaways

12. East Asia Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Product Type

        12.2.3. By Deployment Mode

        12.2.4. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Deployment Mode

        12.3.4. By End Use

    12.4. Key Takeaways

13. South Asia Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Thailand

            13.2.1.3. Malaysia

            13.2.1.4. Indonesia

            13.2.1.5. Rest of South Asia

        13.2.2. By Product Type

        13.2.3. By Deployment Mode

        13.2.4. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Deployment Mode

        13.3.4. By End Use

    13.4. Key Takeaways

14. Oceania Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Product Type

        14.2.3. By Deployment Mode

        14.2.4. By End Use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Deployment Mode

        14.3.4. By End Use

    14.4. Key Takeaways

15. MEA Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.2.1. By Country

            15.2.1.1. GCC

            15.2.1.2. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Deployment Mode

        15.2.4. By End Use

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Deployment Mode

        15.3.4. By End Use

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. U.S.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2021

            16.1.2.1. By Product Type

            16.1.2.2. By Deployment Mode

            16.1.2.3. By End Use

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2021

            16.2.2.1. By Product Type

            16.2.2.2. By Deployment Mode

            16.2.2.3. By End Use

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2021

            16.3.2.1. By Product Type

            16.3.2.2. By Deployment Mode

            16.3.2.3. By End Use

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2021

            16.4.2.1. By Product Type

            16.4.2.2. By Deployment Mode

            16.4.2.3. By End Use

    16.5. Argentina

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2021

            16.5.2.1. By Product Type

            16.5.2.2. By Deployment Mode

            16.5.2.3. By End Use

    16.6. Germany

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2021

            16.6.2.1. By Product Type

            16.6.2.2. By Deployment Mode

            16.6.2.3. By End Use

    16.7. Italy

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2021

            16.7.2.1. By Product Type

            16.7.2.2. By Deployment Mode

            16.7.2.3. By End Use

    16.8. France

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2021

            16.8.2.1. By Product Type

            16.8.2.2. By Deployment Mode

            16.8.2.3. By End Use

    16.9. U.K.

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2021

            16.9.2.1. By Product Type

            16.9.2.2. By Deployment Mode

            16.9.2.3. By End Use

    16.10. Spain

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2021

            16.10.2.1. By Product Type

            16.10.2.2. By Deployment Mode

            16.10.2.3. By End Use

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2021

            16.11.2.1. By Product Type

            16.11.2.2. By Deployment Mode

            16.11.2.3. By End Use

    16.12. BENELUX

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2021

            16.12.2.1. By Product Type

            16.12.2.2. By Deployment Mode

            16.12.2.3. By End Use

    16.13. China

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2021

            16.13.2.1. By Product Type

            16.13.2.2. By Deployment Mode

            16.13.2.3. By End Use

    16.14. Japan

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2021

            16.14.2.1. By Product Type

            16.14.2.2. By Deployment Mode

            16.14.2.3. By End Use

    16.15. South Korea

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2021

            16.15.2.1. By Product Type

            16.15.2.2. By Deployment Mode

            16.15.2.3. By End Use

    16.16. India

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2021

            16.16.2.1. By Product Type

            16.16.2.2. By Deployment Mode

            16.16.2.3. By End Use

    16.17. Thailand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2021

            16.17.2.1. By Product Type

            16.17.2.2. By Deployment Mode

            16.17.2.3. By End Use

    16.18. Malaysia

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2021

            16.18.2.1. By Product Type

            16.18.2.2. By Deployment Mode

            16.18.2.3. By End Use

    16.19. Indonesia

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2021

            16.19.2.1. By Product Type

            16.19.2.2. By Deployment Mode

            16.19.2.3. By End Use

    16.20. Australia

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2021

            16.20.2.1. By Product Type

            16.20.2.2. By Deployment Mode

            16.20.2.3. By End Use

    16.21. New Zealand

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2021

            16.21.2.1. By Product Type

            16.21.2.2. By Deployment Mode

            16.21.2.3. By End Use

    16.22. GCC Countries

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2021

            16.22.2.1. By Product Type

            16.22.2.2. By Deployment Mode

            16.22.2.3. By End Use

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Deployment Mode

        17.3.4. By End Use

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Certara

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Dassault Systemes

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Advanced Chemistry Development

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Simulation Plus Inc

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Schrodinger, Inc.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Chemical Computing Group

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Physiomics Plc

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Rosa & Co. LLC

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Consulting Inc.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Genedata AG

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Instem Group of Companies

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

        18.1.12. PPD, Inc.

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

                18.1.12.5.2. Product Strategy

                18.1.12.5.3. Channel Strategy

        18.1.13. Insilico Biotechnology AG

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

                18.1.13.5.2. Product Strategy

                18.1.13.5.3. Channel Strategy

        18.1.14. Rhenovia Pharma

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

                18.1.14.5.2. Product Strategy

                18.1.14.5.3. Channel Strategy

        18.1.15. LeadInvent Technologies

            18.1.15.1. Overview

            18.1.15.2. Product Portfolio

            18.1.15.3. Profitability by Market Segments

            18.1.15.4. Sales Footprint

            18.1.15.5. Strategy Overview

                18.1.15.5.1. Marketing Strategy

                18.1.15.5.2. Product Strategy

                18.1.15.5.3. Channel Strategy

        18.1.16. Nuventra Pharma

            18.1.16.1. Overview

            18.1.16.2. Product Portfolio

            18.1.16.3. Profitability by Market Segments

            18.1.16.4. Sales Footprint

            18.1.16.5. Strategy Overview

                18.1.16.5.1. Marketing Strategy

                18.1.16.5.2. Product Strategy

                18.1.16.5.3. Channel Strategy

        18.1.17. In Silico Biosciences

            18.1.17.1. Overview

            18.1.17.2. Product Portfolio

            18.1.17.3. Profitability by Market Segments

            18.1.17.4. Sales Footprint

            18.1.17.5. Strategy Overview

                18.1.17.5.1. Marketing Strategy

                18.1.17.5.2. Product Strategy

                18.1.17.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2015-2032

Table 2: Global Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 3: Global Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 4: Global Market Value (US$ Mn) Forecast by End Use, 2015-2032

Table 5: North America Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 6: North America Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 7: North America Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 8: North America Market Value (US$ Mn) Forecast by End Use, 2015-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 10: Latin America Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 11: Latin America Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 12: Latin America Market Value (US$ Mn) Forecast by End Use, 2015-2032

Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 14: Europe Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 15: Europe Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 16: Europe Market Value (US$ Mn) Forecast by End Use, 2015-2032

Table 17: East Asia Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 18: East Asia Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 19: East Asia Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 20: East Asia Market Value (US$ Mn) Forecast by End Use, 2015-2032

Table 21: South Asia Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 22: South Asia Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 23: South Asia Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 24: South Asia Market Value (US$ Mn) Forecast by End Use, 2015-2032

Table 25: Oceania Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 26: Oceania Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 27: Oceania Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 28: Oceania Market Value (US$ Mn) Forecast by End Use, 2015-2032

Table 29: MEA Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 30: MEA Market Value (US$ Mn) Forecast by Product Type, 2015-2032

Table 31: MEA Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032

Table 32: MEA Market Value (US$ Mn) Forecast by End Use, 2015-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Product Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 3: Global Market Value (US$ Mn) by End Use, 2022-2032

Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2015-2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 11: Global Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 14: Global Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 15: Global Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 17: Global Market Attractiveness by Product Type, 2022-2032

Figure 18: Global Market Attractiveness by Deployment Mode, 2022-2032

Figure 19: Global Market Attractiveness by End Use, 2022-2032

Figure 20: Global Market Attractiveness by Region, 2022-2032

Figure 21: North America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 22: North America Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 23: North America Market Value (US$ Mn) by End Use, 2022-2032

Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2015-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 31: North America Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 34: North America Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 37: North America Market Attractiveness by Product Type, 2022-2032

Figure 38: North America Market Attractiveness by Deployment Mode, 2022-2032

Figure 39: North America Market Attractiveness by End Use, 2022-2032

Figure 40: North America Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 42: Latin America Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 43: Latin America Market Value (US$ Mn) by End Use, 2022-2032

Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2015-2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 51: Latin America Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 54: Latin America Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 57: Latin America Market Attractiveness by Product Type, 2022-2032

Figure 58: Latin America Market Attractiveness by Deployment Mode, 2022-2032

Figure 59: Latin America Market Attractiveness by End Use, 2022-2032

Figure 60: Latin America Market Attractiveness by Country, 2022-2032

Figure 61: Europe Market Value (US$ Mn) by Product Type, 2022-2032

Figure 62: Europe Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 63: Europe Market Value (US$ Mn) by End Use, 2022-2032

Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2015-2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 71: Europe Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 74: Europe Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 77: Europe Market Attractiveness by Product Type, 2022-2032

Figure 78: Europe Market Attractiveness by Deployment Mode, 2022-2032

Figure 79: Europe Market Attractiveness by End Use, 2022-2032

Figure 80: Europe Market Attractiveness by Country, 2022-2032

Figure 81: East Asia Market Value (US$ Mn) by Product Type, 2022-2032

Figure 82: East Asia Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 83: East Asia Market Value (US$ Mn) by End Use, 2022-2032

Figure 84: East Asia Market Value (US$ Mn) by Country, 2022-2032

Figure 85: East Asia Market Value (US$ Mn) Analysis by Country, 2015-2032

Figure 86: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: East Asia Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 89: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 90: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 91: East Asia Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 92: East Asia Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 93: East Asia Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 94: East Asia Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 95: East Asia Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 97: East Asia Market Attractiveness by Product Type, 2022-2032

Figure 98: East Asia Market Attractiveness by Deployment Mode, 2022-2032

Figure 99: East Asia Market Attractiveness by End Use, 2022-2032

Figure 100: East Asia Market Attractiveness by Country, 2022-2032

Figure 101: South Asia Market Value (US$ Mn) by Product Type, 2022-2032

Figure 102: South Asia Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 103: South Asia Market Value (US$ Mn) by End Use, 2022-2032

Figure 104: South Asia Market Value (US$ Mn) by Country, 2022-2032

Figure 105: South Asia Market Value (US$ Mn) Analysis by Country, 2015-2032

Figure 106: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: South Asia Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 109: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 110: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 111: South Asia Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 112: South Asia Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 113: South Asia Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 114: South Asia Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 115: South Asia Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 116: South Asia Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 117: South Asia Market Attractiveness by Product Type, 2022-2032

Figure 118: South Asia Market Attractiveness by Deployment Mode, 2022-2032

Figure 119: South Asia Market Attractiveness by End Use, 2022-2032

Figure 120: South Asia Market Attractiveness by Country, 2022-2032

Figure 121: Oceania Market Value (US$ Mn) by Product Type, 2022-2032

Figure 122: Oceania Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 123: Oceania Market Value (US$ Mn) by End Use, 2022-2032

Figure 124: Oceania Market Value (US$ Mn) by Country, 2022-2032

Figure 125: Oceania Market Value (US$ Mn) Analysis by Country, 2015-2032

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: Oceania Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 131: Oceania Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 134: Oceania Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 137: Oceania Market Attractiveness by Product Type, 2022-2032

Figure 138: Oceania Market Attractiveness by Deployment Mode, 2022-2032

Figure 139: Oceania Market Attractiveness by End Use, 2022-2032

Figure 140: Oceania Market Attractiveness by Country, 2022-2032

Figure 141: MEA Market Value (US$ Mn) by Product Type, 2022-2032

Figure 142: MEA Market Value (US$ Mn) by Deployment Mode, 2022-2032

Figure 143: MEA Market Value (US$ Mn) by End Use, 2022-2032

Figure 144: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 145: MEA Market Value (US$ Mn) Analysis by Country, 2015-2032

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 148: MEA Market Value (US$ Mn) Analysis by Product Type, 2015-2032

Figure 149: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 151: MEA Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032

Figure 152: MEA Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032

Figure 154: MEA Market Value (US$ Mn) Analysis by End Use, 2015-2032

Figure 155: MEA Market Value Share (%) and BPS Analysis by End Use, 2022-2032

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End Use, 2022-2032

Figure 157: MEA Market Attractiveness by Product Type, 2022-2032

Figure 158: MEA Market Attractiveness by Deployment Mode, 2022-2032

Figure 159: MEA Market Attractiveness by End Use, 2022-2032

Figure 160: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Chemicals & Materials

Biophotonics Market

Published : May 2021

Chemicals & Materials

Biobased Biodegradable Plastics Market

Published : December 2014

Chemicals & Materials

Asia Pacific Bio Composites Market

Published : January 1970

Chemicals & Materials

Bio-plastics Market

Published : December 2014

Google translate